These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
637 related articles for article (PubMed ID: 9721879)
1. Resistance of human leukemic CEM-C1 cells is overcome by synergism between glucocorticoid and protein kinase A pathways: correlation with c-Myc suppression. Medh RD; Saeed MF; Johnson BH; Thompson EB Cancer Res; 1998 Aug; 58(16):3684-93. PubMed ID: 9721879 [TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid antagonist RU 486 reverses agonist-induced apoptosis and c-myc repression in human leukemic CEM-C7 cells. Thompson EB; Thulasi R; Saeed MF; Johnson BH Ann N Y Acad Sci; 1995 Jun; 761():261-75. PubMed ID: 7625725 [TBL] [Abstract][Full Text] [Related]
3. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor. Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130 [TBL] [Abstract][Full Text] [Related]
4. Constitutive expression of ectopic c-Myc delays glucocorticoid-evoked apoptosis of human leukemic CEM-C7 cells. Medh RD; Wang A; Zhou F; Thompson EB Oncogene; 2001 Aug; 20(34):4629-39. PubMed ID: 11498786 [TBL] [Abstract][Full Text] [Related]
5. Resistance to glucocorticoid-induced apoptosis in human T-cell acute lymphoblastic leukemia CEM-C1 cells is due to insufficient glucocorticoid receptor expression. Geley S; Hartmann BL; Hala M; Strasser-Wozak EM; Kapelari K; Kofler R Cancer Res; 1996 Nov; 56(21):5033-8. PubMed ID: 8895760 [TBL] [Abstract][Full Text] [Related]
6. Regulation of a distinctive set of genes in glucocorticoid-evoked apoptosis in CEM human lymphoid cells. Thompson EB; Johnson BH Recent Prog Horm Res; 2003; 58():175-97. PubMed ID: 12795419 [TBL] [Abstract][Full Text] [Related]
7. Anisomycin induces apoptosis of glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells via activation of mitogen-activated protein kinases p38 and JNK. Liu Y; Ge J; Li Q; Gu L; Guo X; Ma ZG; Zhu YP Neoplasma; 2013; 60(1):101-10. PubMed ID: 23067223 [TBL] [Abstract][Full Text] [Related]
8. Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK. Liu Y; Ge J; Li Q; Guo X; Gu L; Ma ZG; Li XH; Zhu YP Leuk Lymphoma; 2014 Sep; 55(9):2179-88. PubMed ID: 24597985 [TBL] [Abstract][Full Text] [Related]
9. Role of c-jun induction in the glucocorticoid-evoked apoptotic pathway in human leukemic lymphoblasts. Zhou F; Thompson EB Mol Endocrinol; 1996 Mar; 10(3):306-16. PubMed ID: 8833659 [TBL] [Abstract][Full Text] [Related]
10. Role of intracellular free Ca(II) and Zn(II) in dexamethasone-induced apoptosis and dexamethasone resistance in human leukemic CEM cell lines. Adebodun F; Post JF J Cell Physiol; 1995 Apr; 163(1):80-6. PubMed ID: 7896902 [TBL] [Abstract][Full Text] [Related]
11. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211. Miller AL; Webb MS; Copik AJ; Wang Y; Johnson BH; Kumar R; Thompson EB Mol Endocrinol; 2005 Jun; 19(6):1569-83. PubMed ID: 15817653 [TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid mediated transcriptional repression of c-myc in apoptotic human leukemic CEM cells. Zhou F; Medh RD; Thompson EB J Steroid Biochem Mol Biol; 2000; 73(5):195-202. PubMed ID: 11070348 [TBL] [Abstract][Full Text] [Related]
13. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells]. He L; Li D; Hou KZ; Liu YP Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564 [TBL] [Abstract][Full Text] [Related]
14. Pro-apoptotic protein BIM in apoptosis of glucocorticoid-sensitive and -resistant acute lymphoblastic leukemia CEM cells. Zhao YN; Guo X; Ma ZG; Gu L; Ge J; Li Q Med Oncol; 2011 Dec; 28(4):1609-17. PubMed ID: 20697841 [TBL] [Abstract][Full Text] [Related]
15. A novel method to establish glucocorticoid resistant acute lymphoblastic leukemia cell lines. Gu L; Zhang G; Zhang Y J Exp Clin Cancer Res; 2019 Jun; 38(1):269. PubMed ID: 31221196 [TBL] [Abstract][Full Text] [Related]
16. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia. Chen DW; Saha V; Liu JZ; Schwartz JM; Krstic-Demonacos M Oncogene; 2013 Jun; 32(25):3039-48. PubMed ID: 22869147 [TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids in malignant lymphoid cells: gene regulation and the minimum receptor fragment for lysis. Thompson EB; Nazareth LV; Thulasi R; Ashraf J; Harbour D; Johnson BH J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):273-82. PubMed ID: 1314075 [TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids activate somatostatin gene transcription through co-operative interaction with the cyclic AMP signalling pathway. Liu JL; Papachristou DN; Patel YC Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):863-9. PubMed ID: 7914402 [TBL] [Abstract][Full Text] [Related]
19. Honokiol induces apoptosis and autophagy in dexamethasone-resistant T-acute lymphoblastic leukemia CEM-C1 cells. Liu Y; Zhang S; Tan Y Hematology; 2024 Dec; 29(1):2337307. PubMed ID: 38573223 [No Abstract] [Full Text] [Related]
20. Synergistic induction of apoptosis with glucocorticoids and 3',5'-cyclic adenosine monophosphate reveals agonist activity by RU 486. Gruol DJ; Altschmied J Mol Endocrinol; 1993 Jan; 7(1):104-13. PubMed ID: 8383286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]